163 related articles for article (PubMed ID: 28560063)
1. CCR6
He H; Wu J; Zang M; Wang W; Chang X; Chen X; Wang R; Wu Z; Wang L; Wang D; Lu F; Sun Z; Qu C
Am J Cancer Res; 2017; 7(5):1151-1163. PubMed ID: 28560063
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma].
Chang X; Wang L; Zang M; Rong W; Wu Z; Liu L; Du J; Liu J; Wu J; Qu C
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):5-10. PubMed ID: 25877311
[TBL] [Abstract][Full Text] [Related]
3. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S
Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142
[TBL] [Abstract][Full Text] [Related]
4. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
[TBL] [Abstract][Full Text] [Related]
5. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.
Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110
[TBL] [Abstract][Full Text] [Related]
6. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM
Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma.
Rubie C; Frick VO; Wagner M; Rau B; Weber C; Kruse B; Kempf K; Tilton B; König J; Schilling M
Scand J Immunol; 2006 Jun; 63(6):468-77. PubMed ID: 16764701
[TBL] [Abstract][Full Text] [Related]
8. The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma.
Qiu W; Wang G; Sun X; Ye J; Wei F; Shi X; Lv G
Med Oncol; 2015 Mar; 32(3):75. PubMed ID: 25698534
[TBL] [Abstract][Full Text] [Related]
9. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.
Rubie C; Frick VO; Wagner M; Weber C; Kruse B; Kempf K; König J; Rau B; Schilling M
World J Gastroenterol; 2006 Nov; 12(41):6627-33. PubMed ID: 17075975
[TBL] [Abstract][Full Text] [Related]
10. CCL20-CCR6 Cytokine Network Facilitate Treg Activity in Advanced Grades and Metastatic Variants of Hepatocellular Carcinoma.
Li WM; Liu HR
Scand J Immunol; 2016 Jan; 83(1):33-7. PubMed ID: 26331965
[TBL] [Abstract][Full Text] [Related]
11. CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma.
Liu JY; Li F; Wang LP; Chen XF; Wang D; Cao L; Ping Y; Zhao S; Li B; Thorne SH; Zhang B; Kalinski P; Zhang Y
Br J Cancer; 2015 Sep; 113(5):747-55. PubMed ID: 26284335
[TBL] [Abstract][Full Text] [Related]
12. The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver Metastasis.
Jiao X; Shu G; Liu H; Zhang Q; Ma Z; Ren C; Guo H; Shi J; Liu J; Zhang C; Wang Y; Gao Y
J Histochem Cytochem; 2019 May; 67(5):299-308. PubMed ID: 30633620
[TBL] [Abstract][Full Text] [Related]
13. Modulation of chemotactic and pro-inflammatory activities of endothelial progenitor cells by hepatocellular carcinoma.
Shih YT; Wang MC; Peng HH; Chen TF; Chen L; Chang JY; Chiu JJ
Cell Signal; 2012 Mar; 24(3):779-93. PubMed ID: 22120522
[TBL] [Abstract][Full Text] [Related]
14. The Role of CCL20-CCR6 Axis in Ovarian Cancer Metastasis.
Liu W; Wang W; Zhang N; Di W
Onco Targets Ther; 2020; 13():12739-12750. PubMed ID: 33335408
[TBL] [Abstract][Full Text] [Related]
15. EGFR/Ras-induced CCL20 production modulates the tumour microenvironment.
Hippe A; Braun SA; Oláh P; Gerber PA; Schorr A; Seeliger S; Holtz S; Jannasch K; Pivarcsi A; Buhren B; Schrumpf H; Kislat A; Bünemann E; Steinhoff M; Fischer J; Lira SA; Boukamp P; Hevezi P; Stoecklein NH; Hoffmann T; Alves F; Sleeman J; Bauer T; Klufa J; Amberg N; Sibilia M; Zlotnik A; Müller-Homey A; Homey B
Br J Cancer; 2020 Sep; 123(6):942-954. PubMed ID: 32601464
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
[TBL] [Abstract][Full Text] [Related]
17. CrkL meditates CCL20/CCR6-induced EMT in gastric cancer.
Han G; Wu D; Yang Y; Li Z; Zhang J; Li C
Cytokine; 2015 Dec; 76(2):163-169. PubMed ID: 26044596
[TBL] [Abstract][Full Text] [Related]
18. [Effects of hypergravity exposure after 30 days of simulated weightlessness on chemokine CCL20 and its receptor CCR6 in gingival tissue of rhesus macaque].
Tang CH; Niu ZY; Zheng YH; Bao B; Hong B; Chen YH
Shanghai Kou Qiang Yi Xue; 2014 Jun; 23(3):273-9. PubMed ID: 25102866
[TBL] [Abstract][Full Text] [Related]
19. The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients.
Zhang CY; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
Biomed Pharmacother; 2015 Feb; 69():242-8. PubMed ID: 25661365
[TBL] [Abstract][Full Text] [Related]
20. Regulation of CD4⁺FOXP3⁺ T cells by CCL20/CCR6 axis in early unexplained recurrent miscarriage patients.
Zhang XX; Kang XM; Zhao AM
Genet Mol Res; 2015 Aug; 14(3):9145-54. PubMed ID: 26345847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
